Invention Grant
- Patent Title: Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
-
Application No.: US15813910Application Date: 2017-11-15
-
Publication No.: US10251865B2Publication Date: 2019-04-09
- Inventor: Daniel W. Gil , John E. Donello , Veena Viswanath , Lauren M. B. Luhrs
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/4439 ; A61K31/17 ; A61K31/4164 ; A61K31/421 ; A61K31/4168 ; A61K31/4178
Abstract:
Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
Public/Granted literature
- US20180071259A1 METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS Public/Granted day:2018-03-15
Information query
